The Integrated Perinatal Diabetes Education and Management Program (IP-DEMP) was launched to improve outcomes of pregnant and postpartum individuals with diabetes at a large, urban academic hospital system. The purpose of this study was to evaluate treatment outcomes achieved by program participants.
This retrospective cohort study compared diabetes treatment received by participants in the IP-DEMP with diabetes treatment in a historical comparison group at the same health care facility just before implementation of the IP-DEMP. Logistic regression was used to model the association of participation in the intervention with treatment, adjusting for covariates.
A total of 355 people included in the analysis. Descriptive characteristics were similar between the intervention and comparison groups. Among participants with gestational diabetes mellitus (GDM), participation in the intervention group significantly increases the likelihood of receiving insulin, the gold-standard therapy during pregnancy. No significant differences in therapy received were observed among participants with different racial and ethnic identities.
People with GDM who participated in the IP-DEMP were more likely to receive insulin therapy. Treatment received was not different for participants from historically marginalized groups.
